DRKS00026261
Completed
Not Applicable
evaluation of atherosclerotic vascular lesions and terminal diseases as well as cardiovascular risk factors and experimental biomarkers in patients with primary sjögren-syndrome - Ath-pSS
Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung0 sites317 target enrollmentSeptember 6, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- M35.0
- Sponsor
- Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung
- Enrollment
- 317
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for patient population:
- •\- Age of majority (\>18\)
- •\- ability to give informed consent is given
- •\- confirmed diagnosis of primary Sjögren's syndrome (at least 2/3 criteria from the classification criteria for pSS of the American College of Rheumatology/European League Against Rheumatism 2016\)
- •\- At least 5 years cancer free survival
- •Inclusion criteria for control subjects:
- •\- Age of majority (\>18\)
- •\- Ability to give informed consent is given
- •(matched recruitment by age and sex to patient population).
Exclusion Criteria
- •Exclusion criteria for pSS patients
- •\- Active cancer or cancer that occurred less than five years ago.
- •\- Incapable of giving informed consent
- •\- not at the age of majority (\>18 yrs.)
- •\- Pregnancy
- •\- Not fulfilling at least 2/3 classification criteria as defined by the American College of Rheumatology/European League Against Rheumatism of 2016\.
- •\- known arterial occlusive diseases (peripheral arterial occlusive disease, coronary heart disease, stroke, myocardial infarction)
- •Exclusion criteria for control subjects
- •\- not at the age of majority (\>18 yrs.)
- •\- Incapable of giving informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A study to assess the cardiovascular disease risk in Indian patientsCTRI/2024/02/062577Sun Pharma Laboratories Ltd.
Recruiting
Phase 1
Assessment of subclinical atherosclerosis demonstrated by coronary artery calcification in familial hypercholesterolemia patients compared with non-familial hypercholesterolemia patientsfamilial hypercholesterolemianon-familial hypercholesterolemiacoronary artery calcium scoreaortic valve calcium scorehypercholesterolemiaTCTR20201014001Ratchadaphiseksomphot Endowment Fund70
Not yet recruiting
Not Applicable
To find out if subclinical atherosclerosis is more common in patients of psoriasis without metabolic syndrome compared to those patients of psoriasis not having metabolic syndromeHealth Condition 1: L400- Psoriasis vulgarisCTRI/2021/07/035003DR D Y Patil Medical College and Hospital
Completed
Not Applicable
Computed Tomographic Evaluation of Atherosclerotic Determinants of Myocardial Ischemiacoronary artery diseaseischemic heart disease10011082NL-OMON42550ewYork-Presbyterian Hospital and Weill Cornell Medical College20
Completed
Not Applicable
Investigation of the progression of atherosclerosis and atherosclerotic risk factor in patients with diabetesDiabetesJPRN-UMIN000014765Division of diabetes, Mitsui Memorial Hospital700